FDA FY 1995 campus consolidation funds rescinded at the request of Rep. Barton.
This article was originally published in The Tan Sheet
Executive Summary
FDA FY 1995 CAMPUS CONSOLIDATION FUNDS RESCINDED AT REQUEST OF REP. BARTON, who cited the House Commerce Commit-tee's ongoing "full-scale reassessment of the FDA" in a May 3 letter to House Appropriations/Treasury, Postal Service and General Government Subcommittee Chairman Jim Lightfoot (R-Iowa). "It would be premature to restore the Senate's cut of the...FDA-proposed facility until the [Commerce] Committee has completed its review of both the FDA and the implications of this costly project," Oversight & Investigations Subcommittee Chairman Joe Barton (R-Tex.) asserted.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning